Showing results (11-20 of 233) with videos related to
Sort By:
Pageof 24
Psychopharmacology|January 1, 1993
Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivityH Lublin, J Gerlach, L PeacockEuropean Journal of Pharmacology|September 4, 1990
The effects of dopamine D1 and D2 receptor agonists and antagonists in monkeys withdrawn from long-term neuroleptic treatmentL Peacock, H Lublin, J GerlachNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 1, 1996
Extrapyramidal symptoms during long-term treatment with antipsychotics: special focus on clozapine and D1 and D2 dopamine antagonistsJ Gerlach, H Lublin, L PeacockPsychopharmacology|April 1, 1994
Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonistsH Lublin, J Gerlach, F MørkebergClinical Neuropharmacology|December 1, 1992
Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesiaH Lublin, J Gerlach, L PeacockInternational Clinical Psychopharmacology|July 1, 1988
Transient response to amoxapine in depressed patientsP Kristjansen, K Kistrup, H LublinUgeskrift for Laeger|January 18, 1993
[Risk factors for development of low back pain]A Randløv, C Manniche, P KrygerActa Medica Scandinavica|January 1, 1984
Atrial fibrillation--a review of course and prognosisP Petersen, J GodtfredsenEuropean Heart Journal|March 1, 1988
Risk factors for stroke in chronic atrial fibrillationP Petersen, J GodtfredsenPageof 24